PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Neuroblastoma D009447 66 associated lipids
Pain D010146 64 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Parkinson Disease D010300 53 associated lipids
Peptic Ulcer D010437 19 associated lipids
Peritonitis D010538 38 associated lipids
Persistent Fetal Circulation Syndrome D010547 1 associated lipids
Pleurisy D010998 20 associated lipids
Polycystic Ovary Syndrome D011085 14 associated lipids
Adenomatous Polyposis Coli D011125 16 associated lipids
Precancerous Conditions D011230 48 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Respiratory Sounds D012135 3 associated lipids
Retinopathy of Prematurity D012178 9 associated lipids
Rhinitis D012220 10 associated lipids
Rhinitis, Allergic, Perennial D012221 6 associated lipids
Sarcoidosis D012507 13 associated lipids
Sarcoma 180 D012510 21 associated lipids
Osteosarcoma D012516 50 associated lipids
Seizures D012640 87 associated lipids
Sleep Wake Disorders D012893 7 associated lipids
Sneezing D012912 6 associated lipids
Stomach Ulcer D013276 75 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Thrombocytopenia D013921 15 associated lipids
Thrombosis D013927 49 associated lipids
Thyroid Diseases D013959 8 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Thyroiditis, Autoimmune D013967 9 associated lipids
Translocation, Genetic D014178 20 associated lipids
Trigeminal Neuralgia D014277 1 associated lipids
Uremia D014511 33 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Urticaria D014581 13 associated lipids
Urticaria Pigmentosa D014582 4 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Wounds, Stab D014951 3 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Zollinger-Ellison Syndrome D015043 1 associated lipids
Reperfusion Injury D015427 65 associated lipids
Weight Loss D015431 56 associated lipids
Leukemia, B-Cell D015448 3 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Leukemia, Basophilic, Acute D015471 9 associated lipids
HTLV-I Infections D015490 3 associated lipids
Nasal Obstruction D015508 4 associated lipids
Choroid Diseases D015862 2 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Lymphoma, T-Cell D016399 11 associated lipids
Helicobacter Infections D016481 21 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Liver Failure, Acute D017114 11 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Cholangiocarcinoma D018281 7 associated lipids
Coronavirus Infections D018352 4 associated lipids
Respiratory Syncytial Virus Infections D018357 10 associated lipids
Vasculitis, Leukocytoclastic, Cutaneous D018366 5 associated lipids
Carcinoma, Lewis Lung D018827 22 associated lipids
Cystitis, Interstitial D018856 2 associated lipids
Optic Neuropathy, Ischemic D018917 2 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Endotoxemia D019446 27 associated lipids
Thrombophilia D019851 6 associated lipids
Sleep Disorders, Circadian Rhythm D020178 3 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Muscular Dystrophy, Duchenne D020388 11 associated lipids
Stroke D020521 32 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Fetal Weight D020567 12 associated lipids
Parkinsonian Disorders D020734 20 associated lipids
Coronary Restenosis D023903 10 associated lipids
Tauopathies D024801 6 associated lipids
Mastocytosis, Systemic D034721 1 associated lipids
Decapitation D049248 2 associated lipids
Graves Ophthalmopathy D049970 3 associated lipids
Atherosclerosis D050197 85 associated lipids
Angioedemas, Hereditary D054179 2 associated lipids
Idiopathic Pulmonary Fibrosis D054990 4 associated lipids
Acute Lung Injury D055371 33 associated lipids
Pulmonary Aspergillosis D055732 1 associated lipids
Asthma, Aspirin-Induced D055963 2 associated lipids
Airway Remodeling D056151 3 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Fetal Alcohol Spectrum Disorders D063647 6 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Zhuang H et al. Prostaglandins of J series control heme oxygenase expression: potential significance in modulating neuroinflammation. 2003 Ann. N. Y. Acad. Sci. pmid:12853315
Pestel S et al. Inhibition of prostaglandin D2 clearance in rat hepatocytes by the thromboxane receptor antagonists daltroban and ifetroban and the thromboxane synthase inhibitor furegrelate. 2003 Biochem. Pharmacol. pmid:12906929
Pritts EA et al. Peroxisome proliferator-activated receptor-gamma ligand inhibition of RANTES production by human endometriotic stromal cells is mediated through an upstream promoter element. 2003 Fertil. Steril. pmid:12909507
Kim BE et al. Cytochrome C-dependent Fas-independent apoptotic pathway in HeLa cells induced by delta12-prostaglandin J2. 2003 Exp. Mol. Med. pmid:14508070
Armoni M et al. Peroxisome proliferator-activated receptor-gamma represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect. 2003 J. Biol. Chem. pmid:12777391
Liu H et al. PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitro. 2003 Breast Cancer Res. Treat. pmid:12779083
Mitsumori S et al. Synthesis and biological activity of various derivatives of a novel class of potent, selective, and orally active prostaglandin D2 receptor antagonists. 1. Bicyclo[2.2.1]heptane derivatives. 2003 J. Med. Chem. pmid:12773047
Mitsumori S et al. Synthesis and biological activity of various derivatives of a novel class of potent, selective, and orally active prostaglandin D2 receptor antagonists. 2. 6,6-Dimethylbicyclo[3.1.1]heptane derivatives. 2003 J. Med. Chem. pmid:12773048
Ide T et al. Activation of nuclear receptors by prostaglandins. 2003 Thromb. Res. pmid:14592554
Yagami T et al. Novel binding sites of 15-deoxy-Delta12,14-prostaglandin J2 in plasma membranes from primary rat cortical neurons. 2003 Exp. Cell Res. pmid:14597421
Caivano M et al. 15-Deoxy-Delta12,14-prostaglandin J2 regulates endogenous Cot MAPK kinase kinase 1 activity induced by lipopolysaccharide. 2003 J. Biol. Chem. pmid:14557273
Oliva JL et al. The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J2 binds to and activates H-Ras. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12684535
Paumi CM et al. Multidrug resistance protein (MRP) 1 and MRP3 attenuate cytotoxic and transactivating effects of the cyclopentenone prostaglandin, 15-deoxy-Delta(12,14)prostaglandin J2 in MCF7 breast cancer cells. 2003 Biochemistry pmid:12731885
Wanichkul T et al. Cytokine regulation by peroxisome proliferator-activated receptor gamma in human endometrial cells. 2003 Fertil. Steril. pmid:12620489
Monneret G et al. 15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils. 2003 J. Pharmacol. Exp. Ther. pmid:12490611
Takano H and Komuro I Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease. 2002 Jan-Feb J. Diabetes Complicat. pmid:11872377
Monneret G et al. 15-Deoxy-delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils. 2002 J. Immunol. pmid:11907120
Hayaishi O and Urade Y Prostaglandin D2 in sleep-wake regulation: recent progress and perspectives. 2002 Neuroscientist pmid:11843094
Harris SG and Phipps RP Prostaglandin D(2), its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells. 2002 Immunology pmid:11849312
Masamune A et al. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells. 2002 Pancreas pmid:11854617
Diab A et al. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis. 2002 J. Immunol. pmid:11859145
Adams IR and McLaren A Sexually dimorphic development of mouse primordial germ cells: switching from oogenesis to spermatogenesis. 2002 Development pmid:11874911
Mellor EA et al. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. 2002 J. Exp. Med. pmid:11877481
Xie S et al. 15 deoxy delta12,14 PGJ2 induces procoagulant activity in cultured human endothelial cells. 2002 Thromb. Haemost. pmid:11916086
Rovin BH et al. 15-Deoxy-Delta12,14-prostaglandin J2 regulates mesangial cell proliferation and death. 2002 Kidney Int. pmid:11918736
Mondoro TH and Vostal JG Cold temperatures reduce the sensitivity of stored platelets to disaggregating agents. 2002 Platelets pmid:11918832
Noverr MC et al. Production of prostaglandins and leukotrienes by pathogenic fungi. 2002 Infect. Immun. pmid:11748207
Schoppee PD et al. Putative activation of the peroxisome proliferator-activated receptor gamma impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. 2002 Biol. Reprod. pmid:11751282
Fujitani Y et al. Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. 2002 J. Immunol. pmid:11751991
Yagami T et al. Human group IIA secretory phospholipase A2 induces neuronal cell death via apoptosis. 2002 Mol. Pharmacol. pmid:11752212
Fu Y et al. Upregulation of interleukin-8 expression by prostaglandin D2 metabolite 15-deoxy-delta12, 14 prostaglandin J2 (15d-PGJ2) in human THP-1 macrophages. 2002 Atherosclerosis pmid:11755918
Chen GG et al. Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and NF-kappaB in human colon cancer. 2002 Life Sci. pmid:12269390
Suzuki R and Freed AN Heparin inhibits hyperventilation-induced late-phase hyperreactivity in dogs. 2002 Am. J. Respir. Crit. Care Med. pmid:11779726
Shibata T et al. 15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes. 2002 J. Biol. Chem. pmid:11786541
Masamune A et al. Ligands of peroxisome proliferator-activated receptor-gamma block activation of pancreatic stellate cells. 2002 J. Biol. Chem. pmid:11606585
Chen SY et al. 15-Deoxy-delta12,14-prostaglandin J2 induces apoptosis of a thyroid papillary cancer cell line (CG3 cells) through increasing intracellular iron and oxidative stress. 2002 Anticancer Drugs pmid:12187333
Yamamoto S et al. Agents that elevate cyclic AMP induce receptor phosphorylation primarily at serine 331 in HEK 293 cells overexpressing human thromboxane receptor alpha. 2002 Biochem. Pharmacol. pmid:12147288
Sakurai S et al. Retinal capillary pericyte proliferation and c-Fos mRNA induction by prostaglandin D2 through the cAMP response element. 2002 Invest. Ophthalmol. Vis. Sci. pmid:12147615
Saito S et al. Prostaglandin D2 and reproduction. 2002 Am. J. Reprod. Immunol. pmid:12148545
Miyazaki Y et al. Inhibitory effect of peroxisome proliferator-activated receptor-gamma ligands on the expression of IgE heavy chain germline transcripts in the human B cell line DND39. 2002 Biochem. Biophys. Res. Commun. pmid:12150985
Fernández-Tomé Mdel C et al. Phospholipase C inhibitors and prostaglandins differentially regulate phosphatidylcholine synthesis in rat renal papilla. Evidence of compartmental regulation of CTP:phosphocholine cytidylyltransferase and CDP-choline:1,2-diacylglycerol cholinephosphotransferase. 2002 Biochim. Biophys. Acta pmid:12117562
Kohyama T et al. PGD(2) modulates fibroblast-mediated native collagen gel contraction. 2002 Am. J. Respir. Cell Mol. Biol. pmid:12204901
Nencioni A et al. Dendritic cell immunogenicity is regulated by peroxisome proliferator-activated receptor gamma. 2002 J. Immunol. pmid:12133943
Kudoh I et al. [Prostanoids and acute lung injury]. 2002 Masui pmid:12134647
Meier CA et al. Regulation of the interleukin-1 receptor antagonist in THP-1 cells by ligands of the peroxisome proliferator-activated receptor gamma. 2002 Cytokine pmid:12160520
Kwak BR et al. PPARgamma but not PPARalpha ligands are potent repressors of major histocompatibility complex class II induction in atheroma-associated cells. 2002 Circ. Res. pmid:11861426
Shimada T et al. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells. 2002 Gut pmid:11950812
Pestel S et al. Inhibition by prostaglandin E(2) of anaphylatoxin C5a- but not zymosan-induced prostanoid release from rat Kupffer cells. 2002 Lab. Invest. pmid:11950903
Nishida K et al. Inhibition of human chondrosarcoma cell growth via apoptosis by peroxisome proliferator-activated receptor-gamma. 2002 Br. J. Cancer pmid:11953889
Finck BN and Johnson RW Anti-inflammatory agents inhibit the induction of leptin by tumor necrosis factor-alpha. 2002 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:11959686
Bureau F et al. A proinflammatory role for the cyclopentenone prostaglandins at low micromolar concentrations: oxidative stress-induced extracellular signal-regulated kinase activation without NF-kappa B inhibition. 2002 J. Immunol. pmid:11994490
Nosjean O and Boutin JA Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part? 2002 Cell. Signal. pmid:11955950
Kohyama T et al. Prostaglandin D2 inhibits fibroblast migration. 2002 Eur. Respir. J. pmid:11998998
Yu Y et al. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism. 2002 Biochim. Biophys. Acta pmid:12020636
Mujumdar VS et al. Mechanism of constrictive vascular remodeling by homocysteine: role of PPAR. 2002 Am. J. Physiol., Cell Physiol. pmid:11940516
Padilla J et al. Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists. 2002 Clin. Immunol. pmid:11987982
Natarajan C and Bright JJ Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation. 2002 Genes Immun. pmid:11960303
Cuzzocrea S et al. The cyclopentenone prostaglandin 15-deoxy-Delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation. 2002 Mol. Pharmacol. pmid:11961117
Kojima K et al. Effect of PPARgamma ligands on the viability of gastric epithelial cells. 2002 Aliment. Pharmacol. Ther. pmid:11966526
Lee B et al. Prostaglandin D synthase in the prenatal ovine brain and effects of its inhibition with selenium chloride on fetal sleep/wake activity in utero. 2002 J. Neurosci. pmid:12097519
Wang YL et al. Thiazolidinedione activation of peroxisome proliferator-activated receptor gamma can enhance mitochondrial potential and promote cell survival. 2002 J. Biol. Chem. pmid:12082115
Huang WC et al. Superoxide anion-dependent Raf/MEK/ERK activation by peroxisome proliferator activated receptor gamma agonists 15-deoxy-delta(12,14)-prostaglandin J(2), ciglitazone, and GW1929. 2002 Exp. Cell Res. pmid:12083801
Kondo M et al. 15-Deoxy-Delta(12,14)-prostaglandin J(2): the endogenous electrophile that induces neuronal apoptosis. 2002 Proc. Natl. Acad. Sci. U.S.A. pmid:12032289
Krishnaswamy G et al. Regulation of eosinophil-active cytokine production from human cord blood-derived mast cells. 2002 J. Interferon Cytokine Res. pmid:12034046
Sawano H et al. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells. 2002 Kidney Int. pmid:12028436
Zander T et al. Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma. 2002 J. Neurochem. pmid:12065618
Yagami T et al. Group IB secretory phospholipase A2 induces neuronal cell death via apoptosis. 2002 J. Neurochem. pmid:12065654
Fujino T et al. Effects of the prostanoids on the proliferation or hypertrophy of cultured murine aortic smooth muscle cells. 2002 Br. J. Pharmacol. pmid:12055131
Ward C et al. Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism. 2002 J. Immunol. pmid:12055237
Wayman NS et al. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. 2002 FASEB J. pmid:12087064
Lennon AM et al. MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-Delta(12-14)-prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive oxygenated species. 2002 J. Biol. Chem. pmid:12052825
Lappas M et al. Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-Delta(12,14)-PGJ(2) and troglitazone. 2002 J. Clin. Endocrinol. Metab. pmid:12364456
Skolnik PR et al. Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects. 2002 J. Acquir. Immune Defic. Syndr. pmid:12352144
Eligini S et al. 15-deoxy-delta12,14-Prostaglandin J2 inhibits tissue factor expression in human macrophages and endothelial cells: evidence for ERK1/2 signaling pathway blockade. 2002 Thromb. Haemost. pmid:12353085
Suzuki K and Uyeda M Inhibitory properties of antitumor prostaglandins against topoisomerases. 2002 Biosci. Biotechnol. Biochem. pmid:12353631
Haslmayer P et al. The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637. 2002 Int. J. Oncol. pmid:12239635
Clay CE et al. 15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells. 2002 J. Lipid Res. pmid:12401880
Imaizumi T et al. 15-Deoxy-D12,14-prostaglandin J2 inhibits CX3CL1/fractalkine expression in human endothelial cells. 2002 Immunol. Cell Biol. pmid:12406386
Kim SY et al. Effects of tanshinone I isolated from Salvia miltiorrhiza bunge on arachidonic acid metabolism and in vivo inflammatory responses. 2002 Phytother Res pmid:12410540
Jawerbaum A et al. Modulation of nitric oxide concentration and lipid metabolism by 15-deoxy Delta12,14prostaglandin J2 in embryos from control and diabetic rats during early organogenesis. 2002 Reproduction pmid:12417000
Kubata BK et al. A key role for old yellow enzyme in the metabolism of drugs by Trypanosoma cruzi. 2002 J. Exp. Med. pmid:12417633
Nencioni A et al. Cyclopentenone prostaglandins induce caspase activation and apoptosis in dendritic cells by a PPAR-gamma-independent mechanism: regulation by inflammatory and T cell-derived stimuli. 2002 Exp. Hematol. pmid:12225793
Menè P Prostaglandin D2 : a Cinderella of vascular cell biology? 2002 J. Hypertens. pmid:12131515
Hunt MJ and Tyagi SC Peroxisome proliferators compete and ameliorate Hcy-mediated endocardial endothelial cell activation. 2002 Am. J. Physiol., Cell Physiol. pmid:12225971
Negoro H et al. Endogenous prostaglandin D2 synthesis reduces an increase in plasminogen activator inhibitor-1 following interleukin stimulation in bovine endothelial cells. 2002 J. Hypertens. pmid:12131531
Stubbs VE et al. Indomethacin causes prostaglandin D(2)-like and eotaxin-like selective responses in eosinophils and basophils. 2002 J. Biol. Chem. pmid:11980903
Suzuki-Nishimura T and Uchida MK Prostaglandin D2 generation by rat peritoneal mast cells stimulated with Datura stramonium agglutinin and its inhibition by haptenic sugar and wheat germ agglutinin. 2002 Jpn. J. Pharmacol. pmid:12396030
Hashimoto K et al. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells. 2002 Int J Gastrointest Cancer pmid:12630765
Diaz BL et al. Participation of cytosolic phospholipase A2 in eicosanoid generation by mouse bone marrow-derived mast cells. 2002 Adv. Exp. Med. Biol. pmid:12664562
Hammarstrom S et al. Novel eicosanoid activators of PPAR gamma formed by RAW 264.7 macrophage cultures. 2002 Adv. Exp. Med. Biol. pmid:12664608
Satoh T [Neurotrophin-like low molecular weight compounds]. 2002 Nippon Yakurigaku Zasshi pmid:12491808
Gueck T et al. Influence of vitamin E on mast cell mediator release. 2002 Vet. Dermatol. pmid:12464062
Sawyer N et al. Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. 2002 Br. J. Pharmacol. pmid:12466225
Yang X et al. Hypoxic induction of cox-2 regulates proliferation of human pulmonary artery smooth muscle cells. 2002 Am. J. Respir. Cell Mol. Biol. pmid:12444028
Nikitakis NG et al. 15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells. 2002 Br. J. Cancer pmid:12454768
Fahmi H et al. 15d-PGJ(2) is acting as a 'dual agent' on the regulation of COX-2 expression in human osteoarthritic chondrocytes. 2002 Osteoarthr. Cartil. pmid:12435328
Vitzthum H et al. Gene expression of prostanoid forming enzymes along the rat nephron. 2002 Kidney Int. pmid:12371957
Higashi N et al. A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma. 2002 Clin. Exp. Allergy pmid:12372129
Zhang J et al. 15-Deoxy-prostaglandin J(2) inhibits PDGF-A and -B chain expression in human vascular endothelial cells independent of PPAR gamma. 2002 Biochem. Biophys. Res. Commun. pmid:12379230
Nithipatikom K et al. Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion. 2002 Clin. Exp. Metastasis pmid:12498388